Association of Skin Intrinsic Fluorescence with Retinal Microvascular Complications of Long Term Type 1 Diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy

References

• Monnier VM, Bautista O, Kenny D, et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes 1999;48:870–880.
   Google Scholar
• Conway B, Edmundowicz D, Matter N, et al. Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes. Diabetes Technol Ther 2010;12:339–345.
   PubMed Web of Science ®Google Scholar
• Conway BN, Aroda VR, Maynard JD, et al. Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetes. Diabetes Care 2012;35:2331–2336.
   PubMed Web of Science ®Google Scholar
• Conway B, Wang J, Ediger W, et al. Skin fluorescence and type 1 diabetes: a new marker of complication risk. Diabetes 2008;57(Suppl 11):A287.
   Google Scholar
• Shah KM, Clark BR, McGill JB, et al. Relationship between skin intrinsic fluorescence – an indicator of advanced glycation end products – and upper extremity impairments in individuals with diabetes mellitus. Phys Ther 2015;95:1111–1119.
   PubMed Web of Science ®Google Scholar
• Orchard TJ, Lyons TJ, Cleary PA, et al. The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study. Diabetes Care 2013;36:3146–3153.
   PubMed Web of Science ®Google Scholar
• Hull E, Ediger M, Unione A, et al. Noninvasive, optical detection of diabetes: model studies with porcine skin. Opt Express 2004;12:4496–4510.
   PubMed Web of Science ®Google Scholar
• Beisswenger PJ, Howell S, Mackenzie T, et al. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes. Diabetes Technol Ther 2012;14:285–292.
   PubMed Web of Science ®Google Scholar
• Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324–1330.
   PubMed Web of Science ®Google Scholar
• Heikal AA. Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies. Biomark Med 2010;4:241–263.
   PubMed Web of Science ®Google Scholar
• Jacobs K, Navarrete SA, Simm A, et al. The skin autofluorescence reflects the posttranslational glycation grade of the matrix protein collagen. Free Radic Biol Med 2014;75\(Suppl. 1):S34.
   PubMed Web of Science ®Google Scholar
• Cleary PA, Braffett BH, Orchard T, et al. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Technol Ther 2013;15:466–474.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527–532.
   Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989;107:237–243.
   Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217–1228.
   Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801–1815.
   Google Scholar
• Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XXII. The twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008;115:1859–1868.
   Google Scholar
• Pambianco G, Costacou T, Ellis D, et al. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006;55:1463–1469.
   PubMed Web of Science ®Google Scholar
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329: 977–986.
   PubMed Web of Science ®Google Scholar
• Gkogkolou P, Bohm M. Advanced glycation end products: key players in skin aging? Dermatoendocrinology 2012;4:259–270.
   PubMedGoogle Scholar
• Klein R, Klein BE, Moss SE, et al. Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol 1984;119:54–61.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520–526.
   Google Scholar
• Klein BE, Myers CE, Howard KP, et al. Serum lipids and proliferative diabetic retinopathy and macular edema in persons with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. JAMA Ophthalmol 2015;133:503–510.
   PubMed Web of Science ®Google Scholar
• The Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group. Prev Med 1976;5:207–215.
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Chapter 12. Procedures for completing eye examinations. In: U.S. Department of Commerce, editor. Early Treatment Diabetic Retinopathy Study (ETDRS) Manual of Operations. Springfield, VA: NTIS Accession No. PB-85223006; 1985. p. 101–119.
   Google Scholar
• Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Chapter 18. Classification of diabetic retinopathy from stereo color fundus photographs. In: U.S. Department of Commerce, editor. Early Treatment Diabetic Retinopathy Study (ETDRS) Manual of Operations. Springfield, VA: NTIS Accession No. PB-85223006; 1985. p. 207–43.
   Google Scholar
• Grading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5 Suppl.):786–806.
   PubMed Web of Science ®Google Scholar
• Felipe DL, Hempe JM, Liu S, et al. Skin intrinsic fluorescence is associated with hemoglobin A(1c)and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes. Diabetes Care 2011;34:1816–1820.
   PubMed Web of Science ®Google Scholar
• Eny KM, Lutgers HL, Maynard J, et al. GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. Diabetologia 2014;57:1623–1634.
   PubMed Web of Science ®Google Scholar
• Olson BP, Matter NI, Ediger MN, et al. Noninvasive skin fluorescence spectroscopy is comparable to hemoglobin A1c and fasting plasma glucose for detection of abnormal glucose tolerance. J Diabetes Sci Technol 2013;7:990–1000.
   PubMedGoogle Scholar